Several top tech CEOs, once critical of Donald Trump, are now aligning with his administration as he prepares for his second term. This shift is driven by impending regulations on AI, social media safeguards,

OpenAI CEO Altman, 39, and Amazon founder Bezos, 60, have shelled out millions in recent years to longevity labs Retro Biosciences and Altos Labs, respectively. PayPal cofounder Thiel, 57, forked over $1 million to the Methuselah Foundation, a biomedical charity that aims to make 90 the new 50 by 2030.

The world’s three wealthiest people are expected to pop up in Washington, D.C., for Donald Trump’s inauguration and surrounding events—joining a long list of other billionaire attendees.

NEW YORK, Jan 8: Jeff Bezos, Sam Altman, and Peter Thiel have already conquered the tech world, but now they're investing millions in a new battle: the quest for eternal youth. These tech billionaires are pouring vast sums of their fortunes into the race to extend life, fueling the growth of a $25 billion market for life-extending therapies.

World’s-richest-man Elon Musk, Meta CEO Mark Zuckerberg, and Amazon chief Jeff Bezos are slated to attend the forty-seventh president’s inauguration next week, according to NBC News. The tech trio will be seated alongside elected officials and Trump’s Cabinet selections.

High-profile tech billionaires, including Jeff Bezos, Mark Zuckerberg and Elon Musk will sit front and center at President-elect Donald Trump's inauguration.

Amazon founder Jeff Bezos has had a contentious relationship with Donald Trump in the Washington Post. But things appear to have changed in recent months.

Live: Donald Trump is set to hold a campaign-style victory rally in Washington, D.C. on January 19, 2025, just a day before his second inauguration. The rally, featuring prominent figures like Elon Musk and Kid Rock,

If you are an avid TikTok user – or a creator who relies on the platform for income – here’s what you need to know to prepare for its upcoming ban in the U.S.

Biden won't enforce TikTok ban before leaving office, as Trump pledges to save app US has called a threat, official says

A Midtown-based therapeutics company hopes to tap the growing market of anti-aging drugs with a suite of pharmaceutical research, and investors are taking notice. Cambrian Bio recently raised $23 million to advance its portfolio of drug discovery platforms focused on the biological processes that break down with age.